Metraipolis › archive › dc_9802e00c3cec

SGLT2 inhibitors in CKD: are they really effective in all patients? — Europe PMC PMID:40053507

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40053507
DOI
10.1093/ndt/gfaf051
License (as archived)
solo-consultazione
Archived
2026-11-10T05:19:09.704Z
SHA-256 of the archived text
0f479171447ecc03b193f34cfb785bd2c2965c4b6e3a2f7f3c990bee2ae3a39f
Stable URL of this page
https://metraipolis.com/documento/dc_9802e00c3cec

How to cite

SGLT2 inhibitors in CKD: are they really effective in all patients? — Europe PMC PMID:40053507 — Europe PMC (en), https://europepmc.org/article/MED/40053507 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9802e00c3cec (Metraipolis archive dc_9802e00c3cec, sha256 0f479171447ecc03b193f34cfb785bd2c2965c4b6e3a2f7f3c990bee2ae3a39f)
BibTeX
@misc{dc9802e00c3cec,
  title = {SGLT2 inhibitors in CKD: are they really effective in all patients? — Europe PMC PMID:40053507},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40053507},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9802e00c3cec; sha256 0f479171447ecc03b193f34cfb785bd2c2965c4b6e3a2f7f3c990bee2ae3a39f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40053507. Agents can read the archived copy with the MCP tool read_document.